2009
DOI: 10.1111/j.1600-0404.1999.tb00729.x
|View full text |Cite
|
Sign up to set email alerts
|

High prevalence of anti-α-crystallin antibodies in multiple sclerosis: correlation with severity and activity of disease

Abstract: Introduction ‐ The presence of T‐cell reactivity to αB‐crystallin in patients with multiple sclerosis (MS) has suggested that this small molecular weight heat shock protein (Hsp) may be an autoantigen in MS. Material and methods ‐ We have tested the serum of patients with clinically definite MS (n= 30), other inflammatory neurological disease (n= 22), non‐inflammatory neurological disease (n= 42) and healthy individuals (n= 23) for systemic humoral responses to bovine αB‐crystallin, to the homologous chaperone… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(10 citation statements)
references
References 20 publications
0
10
0
Order By: Relevance
“…They are implicated in several autoimmune diseases such as autoimmune arthritis, type 1 diabetes mellitus, atherosclerosis, and MS. 80 The concentration of antia-crystalline antibodies in sera of MS patients correlates with activity as well as severity of the disease. 30 In CSF, IgG antibodies to small HSPs (eg HSP27, lA crystallin and lB crystalline) are not increased, but to HSP70 and HSC70 (heat shock cognate protein 70) are elevated and correlate with the disease course. 31 Increased antibody titers to HSP60 are present in CSF of both patients with MS and with OND.…”
Section: Gadmentioning
confidence: 96%
“…They are implicated in several autoimmune diseases such as autoimmune arthritis, type 1 diabetes mellitus, atherosclerosis, and MS. 80 The concentration of antia-crystalline antibodies in sera of MS patients correlates with activity as well as severity of the disease. 30 In CSF, IgG antibodies to small HSPs (eg HSP27, lA crystallin and lB crystalline) are not increased, but to HSP70 and HSC70 (heat shock cognate protein 70) are elevated and correlate with the disease course. 31 Increased antibody titers to HSP60 are present in CSF of both patients with MS and with OND.…”
Section: Gadmentioning
confidence: 96%
“…15,16 Antibodies that bind to other antigens such as alpha-B-crystallin, alu repeats, myelin basic protein, and myelin-associated glycoprotein have been reported but not rigorously studied. [17][18][19][20] Despite several published attempts to detect and quantify antibodies directed against Lemus et al myelin and nonmyelin antigens in patients with MS, there is no consensus. This lack of a self-directed immune response producing antibodies argues against the hypothesis of MS as an autoimmune disease ( Fig.…”
Section: Autoimmunity Versus Immune-mediated Demyelinationmentioning
confidence: 99%
“…Other viral agents like varicella zoster and rubella are considered as possible risk factors but not causal agents. 40,41 Of note, vitamin D Table 1 Revised criteria for a disease to be considered autoimmune: neuromyelitis optica and multiple sclerosis Criteria for Autoimmune Disease 7 NMO MS Immune response to a precise autoantigen in all patients aquaporin 4 22,23 Multiple antigens have been described, not present in all patients 12,13,[17][18][19][20] Lesion reproducibility after administration of autoantibody or T cells Exacerbation of EAE model after adoptive transfer of neuromyelitis optica Abs 27…”
Section: Is Multiple Sclerosis a Virus-induced Disease?mentioning
confidence: 99%
“…AlphaB-crystallin is a small heat-shock protein found to be increased in brains with demyelination, and elevated levels of antibodies against this protein were detected in serum and CSF of MS patients [238]. Although autoantibodies against AlphaB-crystallin were also observed in patients with OND, approximately 60% of MS patients are positive [238]. In addition, AlphaB-crystallin was increased in the CSF in 100% of MS patients and in approximately 90% of OND patients [239].…”
Section: Part Ii: Discovery Of Novel (Non-imaging) Biomarkersmentioning
confidence: 99%